Post-earnings recap
Reported
Wed, Feb 2, 2011
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Thermo Fisher Scientific's earnings report showed a significant miss on EPS, which likely contributed to the stock's decline of 2.35%. Investors may be concerned about the company's profitability given the lower-than-expected earnings. Without additional context from management, it is difficult to assess the company's future outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.75 | N/A | -20.89% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.